Cooley-Led Construction Software, Biotech Firms Prep IPOs
A venture-backed construction software provider and a biotechnology firm developing therapies for immunological diseases, both advised by Cooley LLP, set price ranges on Monday for initial public offerings estimated to raise...To view the full article, register now.
Already a subscriber? Click here to view full article